HR Versus RFA for HCC in Patients With PHT

Clinical trial NCT02192671 · UNKNOWN

Trial details

NCT number: NCT02192671
Sponsor: Guangxi Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular Liver Neoplasms Neoplasms, Glandular and Epithelial

Start date: 2015-05-01
Primary completion: 2022-08-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.